Epitope Origin: The HA tag is an 9-amino-acid sequence (YPYDVPDYA) engineered for minimal immunogenicity and compatibility with recombinant proteins .
Antibody Type: A mouse-derived monoclonal IgG2b antibody, purified via Protein A chromatography, with high specificity for HA-tagged proteins .
Immunogenicity: The HA tag lacks intrinsic immunogenicity, requiring conjugation to carrier proteins (e.g., OVA or BSA) during antibody production to elicit immune responses .
The antibody is validated for diverse techniques:
Specificity: Exhibits no cross-reactivity with other fusion tags (e.g., FLAG, Myc), as demonstrated in Western blot and immunoprecipitation assays .
Sensitivity: Detects as low as 125 ng of HA-tagged GST fusion proteins in Western blot .
Versatility: Recognizes both N-terminal and C-terminal HA tags, as shown in immunofluorescence studies with HEK293 cells .
CSB-MA000141M0m is an unconjugated monoclonal antibody targeting the HA-Tag. It is derived from a mouse myeloma cell-splenocyte hybridoma. The splenocyte, obtained from a mouse immunized with the HA-Tag synthetic peptide conjugated to KLH, secretes the HA-Tag antibody. This antibody exhibits cross-reactivity with HA-Tag proteins from all species. It corresponds to the mouse IgG2b isotype. Purified using a Protein A-mediated method, this HA-Tag antibody boasts a purity exceeding 95%. Its versatility extends to various applications, including ELISA, Western blotting, immunoprecipitation, immunofluorescence, and flow cytometry.
The HA tag, a 9-amino acid peptide derived from the human influenza virus hemagglutinin (HA), serves as a widely utilized epitope tag in expression vectors. Its non-interference with the bioactivity or biodistribution of the recombinant protein makes it ideal for fusion to either the N-terminal or C-terminal of recombinant proteins, thereby facilitating the detection, isolation, and purification of target proteins.
The HA tag is an epitope tag derived from the surface glycoprotein hemagglutinin of the influenza virus. Researchers use it to localize gene products in various cell types, study protein topology and complexes, identify associated proteins, and characterize newly identified, low abundance, or poorly immunogenic proteins when protein-specific antibodies are not available . The HA tag provides a consistent detection method across different experimental contexts, eliminating the need to generate protein-specific antibodies for each new protein of interest .
The HA tag consists of the amino acid sequence YPYDVPDYA, which corresponds to amino acids 98-106 of the human influenza hemagglutinin protein . This nine-amino acid peptide is recognized by anti-HA antibodies with high specificity. For enhanced detection sensitivity, multimeric versions such as the triple HA tag (HAx3) with the sequence YPYDVPDYAGYPYDVPDYAGYPYDVPDYA can be used, which significantly improves binding affinity to anti-HA antibodies .
HA-tag monoclonal antibodies are primarily used in Western blot, immunocytochemistry/immunofluorescence (ICC/IF), immunoprecipitation (IP), flow cytometry (FC), and ELISA applications . These antibodies enable researchers to detect and analyze proteins tagged with the HA epitope, facilitating studies in molecular biology, cell biology, and biochemical research without requiring protein-specific antibodies . The versatility of HA tag antibodies makes them invaluable for studying protein localization, expression levels, and interactions in cells .
Selecting the appropriate HA antibody clone depends on your specific application. Clone HA.C5 is the most widely used clone for HA tag detection, cited in over 265 publications . Other notable clones include 5B1D10, 18B11H6, 12CA5, 3F10, and 912426 . For immunoprecipitation applications, clone 3F10 has been characterized with a Kd of 0.38 nM for HA and 0.067 nM for HAx3 under immunoprecipitation conditions . When selecting a clone, consider factors such as host species, applications validated, and potential cross-reactivity with endogenous proteins .
Optimal dilutions vary by application and specific antibody clone. Based on the search results, recommended dilutions for common applications are:
Always perform a dilution series to determine the optimal concentration for your specific experimental conditions and protein expression levels .
The position of the HA tag (N-terminal, C-terminal, or internal) can significantly impact detection efficiency. Some antibodies may show position-dependent affinities . For example, GenScript's HA Tag Antibody (A01244) has been validated to recognize HA tags localized at the C-terminal, N-terminal, and internal regions of HA tagged-fusion proteins . When designing your construct, consider that tag accessibility might be affected by protein folding, potentially masking the epitope in certain structural configurations .
For robust experimental design, include the following controls:
Negative control: Untransfected cells or cells transfected with empty vector (without HA-tag)
Positive control: Cells expressing a well-characterized HA-tagged protein (e.g., HA-tagged JNK-1)
Antibody specificity control: Secondary antibody only to assess background
Loading control: For Western blots, include a housekeeping protein detection
These controls help validate antibody specificity and distinguish true signals from background or non-specific binding .
For low-abundance proteins, consider these strategies:
Use multimeric HA tags: Triple HA tags (HAx3) significantly improve binding affinity. The Kd of Roche's 3F10 clone is 0.38 nM for single HA but improves to 0.067 nM for HAx3 .
Optimize antibody concentration: Perform titration experiments to determine the optimal antibody concentration that maximizes signal-to-noise ratio.
Enhanced chemiluminescence (ECL): Use high-sensitivity ECL substrates for Western blot detection .
Signal amplification systems: Consider tyramide signal amplification for immunofluorescence applications.
Longer exposure times: For Western blots, try extended exposure times while monitoring background levels .
Multiple bands in Western blots using HA-tag antibodies can result from several factors:
Protein degradation: Partial degradation of the HA-tagged protein can produce multiple fragments containing the tag .
Early translation termination: Premature termination of translation can result in truncated proteins still containing the HA tag .
Post-translational modifications: Different phosphorylation, glycosylation, or other modification states of your protein.
Non-specific binding: Some antibody clones may cross-react with endogenous proteins .
To address these issues:
Use fresh samples and include protease inhibitors during protein extraction
Optimize lysis conditions to reduce proteolysis
Try different antibody clones with higher specificity
Reduce antibody concentration if non-specific binding is suspected
Consider using monoclonal rather than polyclonal antibodies for increased specificity
For successful immunoprecipitation with HA-tag antibodies:
Antibody selection: Choose clones specifically validated for IP applications. The 3F10 clone has excellent affinity (Kd of 0.38 nM for HA) .
Lysate preparation: Use gentle lysis buffers to preserve protein-protein interactions (e.g., NP-40 or CHAPS-based buffers).
Antibody amount: Typically 1-5 μg of antibody per 500 μg-1 mg of total protein lysate.
Incubation conditions: Incubate overnight at 4°C with gentle rotation to maximize binding.
Washing stringency: Balance between removing non-specific interactions and maintaining specific interactions.
Elution method: Consider specific elution with HA peptide competition to reduce co-elution of the antibody .
For co-immunoprecipitation studies, such as those examining interactions between HA-tagged Rab11 and FLAG-tagged Crag proteins, anti-HA gel can be used to pull down HA-tagged proteins, which then co-immunoprecipitate with their interaction partners .
Fixation methods can significantly impact epitope accessibility and antibody binding in immunocytochemistry:
Paraformaldehyde (PFA) fixation: Most commonly used (typically 4% PFA for 10-15 minutes at room temperature). Preserves cell morphology while allowing adequate epitope accessibility for most HA-tagged proteins.
Methanol fixation: Can provide better accessibility for some internal epitopes but may disrupt certain protein structures.
Glutaraldehyde fixation: Provides stronger fixation but can reduce epitope accessibility due to extensive cross-linking.
For optimal results, R&D Systems' protocol recommends immersion fixation for HEK293 cells expressing HA-tagged proteins, followed by staining with Mouse Anti-HA Tag Monoclonal Antibody (8 μg/mL for 3 hours at room temperature) . If initial experiments show weak signals, try alternative fixation methods or include a permeabilization step with 0.1-0.5% Triton X-100 to enhance antibody access to intracellular epitopes .
Yes, some HA-tag antibodies can cross-react with endogenous proteins containing similar epitopes. For example, Morishita et al. examined the cross-reactivity of the TANA2 clone anti-HA antibody with a human protein array and found it recognized nine human proteins in addition to the HA tag, all of which contained the epitope sequence PDY . This potential cross-reactivity underscores the importance of including proper negative controls in experiments, such as untransfected cells or cells transfected with empty vectors .
To validate antibody specificity:
Compare transfected vs. untransfected: Run Western blots of cells transfected with HA-tagged proteins alongside untransfected controls .
Epitope competition: Pre-incubate the antibody with synthetic HA peptide before application to verify signal reduction.
Multiple antibody clones: Use different antibody clones that recognize the same tag but different epitopes.
Knockout controls: If available, include cells lacking the tagged protein.
Signal correlation: For fluorescence applications, co-express your HA-tagged protein with a fluorescent protein and verify signal colocalization.
Abcam's validation of ab18181 demonstrates this approach by showing specific detection in Western blots comparing HA-tagged protein-expressing cells with control cells .
Clone context-dependency refers to the phenomenon where the affinity of an antibody for its epitope can vary depending on the surrounding amino acid sequences or the structural context in which the epitope is presented. Schüchner et al. suggested that clone 12CA5, raised against a 36-residue peptide from hemagglutinin, might display context-dependent affinities, similar to what they observed with myc tag antibodies .
This context-dependency can affect experimental results by causing variable detection efficiency for the same tag placed in different positions within a protein or in different proteins. To address this:
Validate each new HA-tagged construct independently
Consider testing multiple antibody clones for new constructs
When comparing expression levels between different HA-tagged proteins, be aware that detection efficiency might vary
For critical quantitative comparisons, consider normalizing with internal standards or alternative detection methods
While traditional immunostaining requires fixed cells, developments in antibody technology allow for live cell imaging with HA-tag antibodies:
Cell-permeable antibody fragments: Use smaller formats like single-chain variable fragments (scFv) or camelid nanobodies conjugated to cell-penetrating peptides.
Surface-expressed proteins: For proteins with extracellular HA tags, apply non-permeabilizing conditions with fluorophore-conjugated anti-HA antibodies.
Microinjection: Directly introduce fluorescently labeled anti-HA antibodies into cells.
Split-GFP complementation: Engineer a split-GFP system where one fragment is fused to an anti-HA scFv and the other to your protein of interest.
This approach enables dynamic studies of protein trafficking, turnover, and interactions in living cells, providing temporal information not available from fixed samples .
HA tags are suitable for chromatin immunoprecipitation (ChIP) assays to study protein-DNA interactions. Santa Cruz Biotechnology's rabbit anti-HA (Y-11) has been successfully used in ChIP assays . When comparing tag systems for ChIP:
HA tag advantages: Small size minimizes interference with DNA binding; well-characterized antibodies with high specificity.
HA vs. FLAG tag: Both perform similarly in ChIP, but some studies suggest FLAG may give lower background in certain contexts.
HA vs. His tag: HA typically provides better specificity in chromatin contexts.
HA vs. larger tags (GFP/TAP): Smaller tags like HA are less likely to interfere with chromatin association and protein folding.
For optimal ChIP results with HA tags:
Use antibodies specifically validated for ChIP applications
Optimize crosslinking conditions (1% formaldehyde for 10 minutes is typical)
Include appropriate controls (input chromatin, IgG controls, untagged samples)
Consider dual crosslinking with DSG followed by formaldehyde for proteins with indirect DNA interactions
"Spaghetti monster" constructs represent an advanced approach to epitope tagging, where multiple copies of the HA tag are incorporated into a single protein in a structurally optimized arrangement . These constructs offer several advantages:
Dramatically increased signal intensity: The presence of multiple epitopes allows for binding of more antibodies per molecule, enhancing detection sensitivity.
Improved spatial resolution: Particularly beneficial for super-resolution microscopy techniques like STORM or PALM.
Lower concentration requirements: Can detect proteins expressed at physiological levels.
Enhanced tracking capabilities: Facilitates single-molecule tracking in live cells.
Reduced photobleaching concerns: The higher signal-to-noise ratio makes imaging less sensitive to fluorophore bleaching.
This approach is particularly valuable for studying low-abundance proteins or for applications requiring high spatial precision, such as mapping protein distributions within complex subcellular structures .
Each epitope tag system has distinct advantages and limitations for different applications:
Tag System | Size | Sensitivity | Background | Best Applications | Limitations |
---|---|---|---|---|---|
HA Tag | 9 aa | High | Low-Medium | WB, IF, IP, ChIP | Some antibody cross-reactivity |
FLAG Tag | 8 aa | High | Very Low | IP, Purification | Slightly lower sensitivity in some WB applications |
Myc Tag | 10 aa | High | Medium | WB, IF, IP | Context-dependent affinities |
His Tag | 6-10 aa | Medium | Low | Purification, WB | Lower sensitivity in IF |
GFP/Fluorescent Tags | ~238 aa | Very High | Low | Live imaging | Large size may affect protein function |
HA tag is one of the most commonly used tag systems alongside c-Myc and His6 . When choosing between systems, consider the specific requirements of your experiment, protein characteristics, and detection method .
The decision between monoclonal and polyclonal HA antibodies should be based on specific experimental needs:
Monoclonal Antibodies:
Provide consistent lot-to-lot reproducibility
Offer high specificity for a single epitope
Reduce background in most applications
Preferred for quantitative analyses
Polyclonal Antibodies:
May provide higher sensitivity by recognizing multiple epitopes
Can be more robust to minor epitope changes or denaturation
May show higher batch-to-batch variability
Potentially higher background in some applications
For most HA tag applications, monoclonal antibodies are preferable due to their consistency and specificity . Specific clones like HA.C5 (Abcam), 5B1D10 (ThermoFisher), and 3F10 (MilliporeSigma) have been extensively validated across multiple applications .
To quantitatively compare antibody sensitivities:
Standard curve approach: Prepare serial dilutions of purified HA-tagged recombinant protein at known concentrations.
Limit of detection (LOD) determination: The lowest concentration that produces a signal significantly different from background (typically defined as background + 3× standard deviation of background).
Dilution series comparison: Test different antibodies at their optimal dilutions against the same samples.
Signal-to-noise ratio calculation: Divide specific signal intensity by background signal intensity.
Western blot sensitivity: Compare band intensities at different exposure times using densitometry.
When comparing antibodies from different suppliers, consider both sensitivity and dilution factors. An antibody with 1:5000 dilution is effectively ten times more economical than one requiring 1:500 dilution for the same application .
HA-tag detection systems are increasingly being integrated with cutting-edge microscopy approaches:
Super-resolution microscopy: Techniques like STORM, PALM, and STED combined with HA-tag immunofluorescence enable visualization of protein localization with nanometer precision, far beyond the diffraction limit of conventional microscopy.
Expansion microscopy: Physical expansion of specimens after HA immunolabeling allows standard microscopes to achieve super-resolution-like results.
Correlative light and electron microscopy (CLEM): HA tags can be detected with both fluorescent antibodies and gold-conjugated antibodies, allowing correlation between fluorescence and electron microscopy images.
Lattice light-sheet microscopy: Combines with HA tag detection for high-speed, low-phototoxicity 3D imaging of living cells.
These integrations enable researchers to address previously intractable questions about protein organization, dynamics, and interactions at the nanoscale level .
Recent advances in multiplexed detection systems incorporating HA tags include:
Multi-tag strategies: Combining HA with other epitope tags (FLAG, Myc, V5) for simultaneous detection of multiple proteins with distinct spectral signatures.
Orthogonal labeling chemistries: Using HA tags alongside enzymatic tags (SNAP, CLIP, Halo) and fluorescent proteins for multicolor imaging.
Sequential epitope detection: Cyclic immunofluorescence methods that allow serial labeling, imaging, and stripping of antibodies to detect dozens of epitopes in the same sample.
Mass cytometry applications: HA tag detection with metal-conjugated antibodies for high-parameter single-cell analysis.
Spatial transcriptomics integration: Combining HA-tagged proteins with RNA detection methods for correlative protein-RNA localization studies.
These multiplexed approaches are particularly valuable for studying complex protein interaction networks and cellular pathways .
To ensure reproducible research with HA-tag antibodies:
Detailed reporting: Document the specific clone, catalog number, lot, dilution, and incubation conditions in publications.
Validation: Include proper controls in each experiment and validate antibody performance in your specific experimental system.
Standardization: Use consistent protocols and reagents across experiments.
Tag position considerations: Be aware that tag positioning (N-terminal, C-terminal, internal) may affect detection efficiency .
Antibody selection: Choose monoclonal over polyclonal antibodies when possible for consistent results .
Multiple detection methods: Confirm key findings using complementary techniques.
Antibody validation: Verify specificity through appropriate controls, including untransfected cells or empty vector controls .
Following these practices enhances the reliability and reproducibility of research using HA-tag antibodies.
When encountering problems with HA-tag detection, follow this systematic troubleshooting approach:
No signal detected:
Verify expression of the tagged protein (check transcript levels)
Confirm tag is in-frame with the protein-coding sequence
Try alternative antibody clones or fresh antibody aliquots
Adjust antibody concentration and incubation conditions
Consider tag accessibility issues due to protein folding
Multiple bands or high background:
Optimize antibody dilution (excessive antibody concentration often causes high background)
Increase washing stringency
Use freshly prepared samples with protease inhibitors to prevent degradation
Try alternative blocking reagents (BSA vs. milk)
Consider using monoclonal instead of polyclonal antibodies for higher specificity
Inconsistent results:
Standardize all experimental conditions
Use the same lot of antibody when possible
Document all protocol details for reproducibility
Consider influence of cell confluence, transfection efficiency, and expression levels